Neogenica BioScience Ltd. (Neogenica) is an online offshore registered MNE pharmaceutical company (Pharmaceutical Permit License-PPL 4570/00), specializing in the field of growth peptide research & development. Neogenica is located in China, with distributors all over the world. All our products are contract manufactured under our brand name by leading Chinese biopharmaceutical companies.

The company is specifically focused on the development & production of rHGH and rIGF-1. Neogenica aims to bring excellent quality growth peptides in the most stable manner. Our other objective is to release our products at the best and most economical prices to the consumer. HGH and IGF should be reachable to greater population.

Neogenica has utilized the latest technological advances in contract manufacturing, labor output, offshore location plants, plus many more efficient means of operations. All of which have led to cost savings and efficient production for us, which in turn has led us to pass these cost savings onto you the client.

Neogenica specialize in supplying pharmaceuticals to the world wide market in the most professional, efficient, discrete & secure manner.